Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Immutep receives French R&D rebate, lifting recent tax incentive funding to about $3 million

Immutep Limited (IMM) · Health care

IMM: $0.024 +9.09% · MC: $35M

Immutep received approximately A$2 million from France’s R&D tax incentive for eligible research conducted in 2025, following an Australian R&D rebate of about A$1 million announced last month. The company says the non-dilutive funding will support research on eftilagimod alfa and IMP761, and its expected cash reach extends into the first half of 2028.

Source announcements: 2026-10-28 11:11 to 2026-10-28 11:11 Sydney time
Story updated 2026-10-28 11:20 Sydney time
SourcesImmutep Receives A$2.16 million French R&D Tax Incentive
Comments